These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1420 related articles for article (PubMed ID: 22828243)
1. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors]. Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243 [TBL] [Abstract][Full Text] [Related]
2. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening]. Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163 [TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804 [TBL] [Abstract][Full Text] [Related]
4. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)]. Magnani C; Gillio Tos A; De Marco L; Calvia M; Cipelletti A; Bestagini P; Pagano E; Segnan N; Ronco G Epidemiol Prev; 2012; 36(2):88-94. PubMed ID: 22706358 [TBL] [Abstract][Full Text] [Related]
5. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening]. Della Palma P; Moresco L; Giorgi Rossi P Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174 [TBL] [Abstract][Full Text] [Related]
6. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804 [TBL] [Abstract][Full Text] [Related]
7. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia. Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411 [TBL] [Abstract][Full Text] [Related]
8. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N; J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502 [TBL] [Abstract][Full Text] [Related]
9. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Gilham C; Sargent A; Kitchener HC; Peto J Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027 [TBL] [Abstract][Full Text] [Related]
10. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology. Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361 [TBL] [Abstract][Full Text] [Related]
11. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population]. Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341 [No Abstract] [Full Text] [Related]
12. Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms. Ronco G; Zappa M; Franceschi S; Tunesi S; Caprioglio A; Confortini M; Del Mistro A; Carozzi F; Segnan N; Zorzi M; Giorgi-Rossi P; Eur J Cancer; 2016 Nov; 68():148-155. PubMed ID: 27755998 [TBL] [Abstract][Full Text] [Related]
13. hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi). Carozzi FM; Iossa A; Scalisi A; Sideri M; Andersson KL; Confortini M; Del Mistro A; Maina G; Ronco G; Raggi P; Schiboni ML; Zappa M; Giorgi Rossi P Epidemiol Prev; 2015; 39(3 Suppl 1):84-90. PubMed ID: 26405780 [TBL] [Abstract][Full Text] [Related]
14. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors. Cox JT; Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506 [TBL] [Abstract][Full Text] [Related]
15. Indicators for monitoring screening programs with primary HPV test. Zorzi M; Giorgi Rossi P; Epidemiol Prev; 2017; 41(1 Suppl 1):1-32. PubMed ID: 28322534 [TBL] [Abstract][Full Text] [Related]
16. Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy. Porras C; Wentzensen N; Rodríguez AC; Morales J; Burk RD; Alfaro M; Hutchinson M; Herrero R; Hildesheim A; Sherman ME; Wacholder S; Solomon D; Schiffman M Int J Cancer; 2012 Apr; 130(8):1879-87. PubMed ID: 21607948 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376 [TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme. Pasquale L; Giorgi Rossi P; Carozzi F; Pedretti C; Ruggeri C; Scalvinoni V; Cotti Cottini M; Tosini A; Morana C; Chiaramonte M; Sacristani M; Cirelli R; Chiudinelli D; Piccolomini M; Marchione R; Romano L; Domenighini S; Pieracci G; Confortini M J Med Screen; 2015 Mar; 22(1):38-48. PubMed ID: 25431452 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. Kim JJ; Wright TC; Goldie SJ JAMA; 2002 May; 287(18):2382-90. PubMed ID: 11988059 [TBL] [Abstract][Full Text] [Related]
20. Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia. Canfell K; Saville M; Caruana M; Gebski V; Darlington-Brown J; Brotherton J; Heley S; Castle PE BMJ Open; 2018 Jan; 8(1):e016700. PubMed ID: 29374658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]